Evidence map›Paper›PMID 31179969›Full record

ArticleJournal of the International Neuropsychological Society : JINS2019

Conditional Effects of Lifetime Alcohol Consumption on Methamphetamine-Associated Neurocognitive Performance.

Rowan Saloner, Emily W Paolillo, Anya Umlauf, David J Moore, Robert K Heaton, Igor Grant, Mariana Cherner, TMARC Group

Abstract read
In one paragraph

Article in Journal of the International Neuropsychological Society : JINS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Rowan SalonerSan Diego State University/University of California, San Diego Joint Doctoral Program in Clinical Psychology, 6363 Alvarado Court, Suite 102, San Diego, CA 92120, USA.
Emily W PaolilloSan Diego State University/University of California, San Diego Joint Doctoral Program in Clinical Psychology, 6363 Alvarado Court, Suite 102, San Diego, CA 92120, USA.
Anya UmlaufDepartment of Psychiatry, University of California, HIV Neurobehavioral Research Program, 220 Dickinson Street, Suite B, San Diego, CA 92103, USA.
David J MooreDepartment of Psychiatry, University of California, HIV Neurobehavioral Research Program, 220 Dickinson Street, Suite B, San Diego, CA 92103, USA.
Robert K HeatonDepartment of Psychiatry, University of California, HIV Neurobehavioral Research Program, 220 Dickinson Street, Suite B, San Diego, CA 92103, USA.
Igor GrantDepartment of Psychiatry, University of California, HIV Neurobehavioral Research Program, 220 Dickinson Street, Suite B, San Diego, CA 92103, USA.
Mariana ChernerDepartment of Psychiatry, University of California, HIV Neurobehavioral Research Program, 220 Dickinson Street, Suite B, San Diego, CA 92103, USA.
TMARC Group
San Diego State University · US

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jennifer E Iudicello · 2001 to 2026
$50.4M
Translational Methamphetamine AIDS Research Center (TMARC)P50DA026306 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRANT, IGOR · 2009 to 2018
$33.9M
NEUROMOTORP01DA012065 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JERNIGAN, TERRY L. · 1999 to 2009
$17.8M
Alcohol Research in the Science/Practitioner ModelT32AA013525 · NIAAA · SAN DIEGO STATE UNIVERSITY · PI EDWARD P RILEY, ANDREA SPADONI TOWNSEND · 2002 to 2026
$8.4M
Mentoring Clinical Researchers at the Intersection of NeuroHIV and Substance AbuseK24DA040550 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHERNER, MARIANA · 2015 to 2025
$1.8M
CYP2D6 Genotype and Cognitive Deficits in Methamphetamine Users with/without HIVR01DA035736 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHERNER, MARIANA · 2013 to 2015
$1.1M
COMT Genotype and Risky Decision Making in HIV and Methamphetamine DependenceR01DA026334 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHERNER, MARIANA · 2009 to 2010
$1.1M
SuperAging in HIV-infected Adults: Biopsychosocial Predictors of Neurocognitive Aging TrajectoriesF31AG064989 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SALONER, ROWAN · 2019 to 2021
$118k
NIAAA NIH HHS T32 AA013525NIA NIH HHS F31 AG064989NIDA NIH HHS K24 DA040550NIDA NIH HHS P01 DA012065NIDA NIH HHS P50 DA026306NIDA NIH HHS R01 DA026334NIDA NIH HHS R01 DA035736NIMH NIH HHS P30 MH062512
6 · The paper itself

Abstract

objectivesMethamphetamine (MA) dependence contributes to neurotoxicity and neurocognitive deficits. Although combined alcohol and MA misuse is common, how alcohol consumption relates to neurocognitive performance among MA users remains unclear. We hypothesized that alcohol and MA use would synergistically diminish neurocognitive functioning, such that greater reported alcohol consumption would exert larger negative effects on neurocognition among MA-dependent individuals compared to MA-nonusing persons.

methodsEighty-seven MA-dependent (MA+) and 114 MA-nonusing (MA-) adults underwent neuropsychological and substance use assessments. Linear and logistic regressions examined the interaction between MA status and lifetime average drinks per drinking day on demographically corrected global neurocognitive T scores and impairment rates, controlling for recent alcohol use, lifetime cannabis use, WRAT reading performance, and lifetime depression.

resultsMA+ displayed moderately higher rates of impairment and lower T scores compared to MA-. Lifetime alcohol use significantly interacted with MA status to predict global impairment (ORR = 0.70, p = .003) such that greater lifetime alcohol use increased likelihood of impairment in MA-, but decreased likelihood of impairment in MA+. Greater lifetime alcohol use predicted poorer global T scores among MA- (b = -0.44, p = .030) but not MA+ (b = 0.08, p = .586).

conclusionsContrary to expectations, greater lifetime alcohol use related to reduced risk of neurocognitive impairment among MA users. Findings are supported by prior research identifying neurobiological mechanisms by which alcohol may attenuate stimulant-driven vasoconstriction and brain thermotoxicity. Replication and examination of neurophysiologic mechanisms underlying alcohol use in the context of MA dependence are warranted to elucidate whether alcohol confers a degree of neuroprotection.

Indexed as

AdultAlcohol DrinkingAmphetamine-Related DisordersCentral Nervous System DepressantsCentral Nervous System StimulantsCognitive DysfunctionEthanolFemaleHumansMaleMethamphetamineMiddle AgedNeuropsychological TestsCentral Nervous System DepressantsCentral Nervous System StimulantsEthanolMethamphetaminecognitive dysfunctionethanolmethamphetamineneuroprotectionneuropsychologySubstance-related disorders

Identifiers

PMID31179969
PMCPMC6733657
OpenAlexW2952654766

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.